about
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...
Read More
1.08
-0.09
(-7.69%)
246.5K
XNAS Volume
High vol. this week
XNAS 21 Sep, 2026 4:15 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BioCardia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..